FCER2 antibody (AA 221-321)
-
- Target See all FCER2 Antibodies
- FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))
-
Binding Specificity
- AA 221-321
-
Reactivity
- Human, Mouse
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This FCER2 antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), Western Blotting (WB), ELISA
- Cross-Reactivity
- Human, Mouse
- Predicted Reactivity
- Rat,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CD23
- Isotype
- IgG
- Top Product
- Discover our top product FCER2 Primary Antibody
-
-
- Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Expiry Date
- 12 months
-
- Target
- FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))
- Alternative Name
- CD23/Fc EpsilonR 2 (FCER2 Products)
- Synonyms
- BLAST-2 antibody, CD23 antibody, CD23A antibody, CLEC4J antibody, FCE2 antibody, IGEBF antibody, Fcer2a antibody, Fc fragment of IgE receptor II antibody, FCER2 antibody, Fcer2 antibody
- Background
-
Synonyms: CD23, FCE2, CD23A, IGEBF, CLEC4J, BLAST-2, Low affinity immunoglobulin epsilon Fc receptor, C-type lectin domain family 4 member J, Fc-epsilon-RII, Immunoglobulin E-binding factor, Lymphocyte IgE receptor, FCER2
Background: Low-affinity receptor for immunoglobulin E (IgE) and CR2/CD21. Has essential roles in the regulation of IgE production and in the differentiation of B-cells (it is a B-cell-specific antigen).
- Gene ID
- 2208
- UniProt
- P06734
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-